Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

BGWHD2E:LX

36.29 EUR 0.23 0.64%

As of 00:59:30 ET on 05/27/2015.

Snapshot for BlackRock Global Funds - World Healthscience Fund (BGWHD2E)

Year To Date: +23.48% 3-Month: +7.81% 3-Year: - 52-Week Range: 22.37 - 37.05
1-Month: +0.06% 1-Year: +63.32% 5-Year: - Beta vs NDWUHC: 1.05

Mutual Fund Chart for BGWHD2E

No chart data available.
  • BGWHD2E:LX 36.29
  • 1M
  • 1Y
Interactive BGWHD2E Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BGWHD2E

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 10-25-2012 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for BGWHD2E

NAV (on 2015-05-27) 36.29
Assets (M) (on 2015-03-31) 3,627.61
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 1,000.00

Dividends for BGWHD2E

No dividends reported

Fees & Expenses for BGWHD2E

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BGWHD2E

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 1,365,600 135,182,168 3.814%
Biogen Inc 313,807 132,501,868 3.738%
Roche Holding AG 464,800 128,294,945 3.620%
UnitedHealth Group Inc 1,051,333 124,362,181 3.509%
Celgene Corp 1,005,908 115,961,074 3.272%
Actavis plc 385,877 114,844,713 3.240%
Amgen Inc 636,100 101,680,585 2.869%
Medtronic PLC 1,290,079 100,613,261 2.839%
Merck & Co Inc 1,723,200 99,049,536 2.795%
Bristol-Myers Squibb Co 1,526,200 97,875,206 2.762%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil